Evolutionary Therapy for Rhabdomyosarcoma
Clinical trial NCT04388839 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04388839
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2026-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.